Oric Pharmaceuticals (ORIC) Total Liabilities (2019 - 2026)

Oric Pharmaceuticals' Total Liabilities history runs 8 years deep, the most recent figure standing at $21.2 million for Q1 2026.

• Quarterly Total Liabilities fell 8.28% year-over-year to $21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (down 8.28% YoY) and the FY2025 annual result came in at $24.5 million, down 20.93% from the prior year.
• Total Liabilities was $21.2 million for Q1 2026 at Oric Pharmaceuticals, down from $24.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $31.0 million in Q4 2024 and bottomed at $21.2 million in Q1 2026.
• A 5-year average of $24.6 million and a median of $23.8 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 178.8% — and 2025, when it retreated 20.93%.
• Oric Pharmaceuticals' Total Liabilities stood at $24.8 million in 2022, then rose by 12.45% to $27.9 million in 2023, then advanced by 11.11% to $31.0 million in 2024, then fell by 20.93% to $24.5 million in 2025, then slipped by 13.55% to $21.2 million in 2026.
• Business Quant data shows ORIC's Total Liabilities at $21.2 million in Q1 2026, $24.5 million in Q4 2025, and $24.3 million in Q3 2025.